Skip to main content

Table 2 Basic information about patients with LN

From: Use of belimumab in treating patients with systemic lupus erythematosus: a single-center, real-world retrospective study

Characteristic

SLE-LN patients(n = 56)

24-hour urine protein quantification(g/d)

2.15 ± 1.94

Serum albumin(g/L)

34.76 ± 7.07

Serum creatinine(µmol/L)

68.8 ± 30.8

Renal biopsy pathology(n = 47)

 

III

6/47(12.8%)

IV

18/47(38.3%)

V

8/47(17.0%)

IV+V

15/47(31.9%)